ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,872Medicare Part D Prescriptions Filled, Including Refills

Rank: 278 out of 783

$656K Total Retail Price of All Prescriptions

Rank: 163 out of 783

267 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 267 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 7,196 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 340 290 1 1
BYSTOLIC 306 269 2 99
ISOSORBIDE MONONITRATE ER 249 216 3 40
DIGOXIN 183 164 4 61
SPIRONOLACTONE 179 147 5 57
OMEPRAZOLE 175 172 6 6
CARVEDILOL 158 140 7 21
SIMVASTATIN 158 138 7 3
METOPROLOL SUCCINATE 154 139 9 13
EVISTA 147 147 10 92
FUROSEMIDE 143 128 11 7
TRAMADOL HCL 131 131 12 20
WARFARIN SODIUM 131 106 12 10
DILTIAZEM 24HR ER 128 118 14 122
VYTORIN 123 123 15 161
ALLOPURINOL 121 110 16 31
AGGRENOX 116 116 17 196
DILTIAZEM 24HR CD 113 97 18 118
ZOLPIDEM TARTRATE 110 110 19 23
POTASSIUM CHLORIDE 102 98 20 16
DIOVAN HCT 97 97 21 94
METFORMIN HCL 94 94 22 8
KLOR-CON M20 92 91 23 48
GABAPENTIN 87 87 24 15
TAMSULOSIN HCL 83 75 25 26
METOPROLOL TARTRATE 81 77 26 9
DIOVAN 77 72 27 49
HYDROCHLOROTHIAZIDE 73 73 28 12
DILTIAZEM ER 72 68 29 153
HYDROCODONE-ACETAMINOPHEN 71 70 S3 30 2
TRAMADOL HCL-ACETAMINOPHEN 69 69 31 167
ZETIA 67 55 32 80
METHYLPREDNISOLONE 67 66 32 138
NEXIUM 65 48 34 28
BUMETANIDE 64 57 35 131
LISINOPRIL 59 59 36 4
CYMBALTA 58 58 37 35
SYNTHROID 58 57 37 47
AMLODIPINE BESYLATE 58 46 37 5
CEPHALEXIN 55 53 40 70
JANUMET 55 55 40 217
SINGULAIR 53 53 42 90
TRIAMTERENE-HCTZ 53 53 42 42
ADVAIR DISKUS 52 51 44 50
COUMADIN 51 51 45 184
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.